Literature DB >> 35305262

When transversus abdominis release (TAR) is not enough during the repair of large midline incisional hernias: the double peritoneal flap to the rescue.

Joaquín-Salvelio Picazo Yeste1, Jerónimo Riquelme-Gaona2.   

Abstract

Transversus abdominis release (TAR) is becoming an increasingly popular approach to incisional hernia repair. As the technique has been applied to more complex hernias, it appears insufficient for repairing large defects due to the impossibility to achieve a tension-free reapproximation of the peritoneum and/or the linea alba, then a bridged repair with interposed omentum, reabsorbable or coated prosthesis frequently leaving the mesh in contact with the subcutaneous space, has been proposed. To overcome these setbacks, we have developed the double peritoneal flap-TAR (DPF-TAR) technique, which entails placement of a retromuscular mesh completely isolated from either peritoneal cavity and subcutaneous space by joining both peritoneal sac halves into a double-bridged design. Of 19 patients, 17 (89%) were available for the study. Median transverse diameter of the hernia was 13,3 cm (10-17), and 10 (53%) cases had a complete failure of the linea alba. Five (26%) patients developed a surgical site occurrence (SSO). With a median follow-up of 11 (4-28) months, one (5,8%) recurrence and four (23,5%) wound bulging were diagnosed. We suggest that DPF-TAR approach can provide an effective repair using native tissues to isolate the retromuscular mesh, with acceptable failure and SSOs rates. By avoiding the need for a steep learning curve, this method may constitute a handy complement to the surgeon's armory for difficult reconstructions of the abdominal wall.
© 2022. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Anterior fascia; Bridged; Peritoneal fold; Synthetic mesh; TAR; Transversus abdominis release

Year:  2022        PMID: 35305262     DOI: 10.1007/s13304-022-01278-6

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  7 in total

1.  Multilayer myofascial-mesh repair for giant midline incisional hernias: a novel advantageous combination of old and new techniques.

Authors:  Joaquín Picazo-Yeste; Antonio Morandeira-Rivas; Carlos Moreno-Sanz
Journal:  J Gastrointest Surg       Date:  2013-07-19       Impact factor: 3.452

2.  Systematic review of transversus abdominis release in complex abdominal wall reconstruction.

Authors:  J A Wegdam; J M M Thoolen; S W Nienhuijs; N de Bouvy; T S de Vries Reilingh
Journal:  Hernia       Date:  2018-12-11       Impact factor: 4.739

3.  Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction.

Authors:  Yuri W Novitsky; Heidi L Elliott; Sean B Orenstein; Michael J Rosen
Journal:  Am J Surg       Date:  2012-05-16       Impact factor: 2.565

4.  Primary uncomplicated midline ventral hernias: factors that influence and guide the surgical approach.

Authors:  H Alkhatib; A Fafaj; M Olson; T Stewart; D M Krpata
Journal:  Hernia       Date:  2019-10-10       Impact factor: 4.739

5.  Medialization after combined anterior and posterior component separation in giant incisional hernia surgery, an anatomical study.

Authors:  Dimitri Sneiders; Gijs H J de Smet; Floris den Hartog; Laura Verstoep; Anand G Menon; Filip E Muysoms; Gert-Jan Kleinrensink; Johan F Lange
Journal:  Surgery       Date:  2021-08-18       Impact factor: 3.982

6.  Watchful waiting is an appropriate option for peritoneal dialysis candidates with an asymptomatic ventral hernia.

Authors:  J D Thomas; A Fafaj; S J Zolin; R Naples; C M Horne; C C Petro; A S Prabhu; D M Krpata; M J Rosen; S Rosenblatt
Journal:  Hernia       Date:  2020-06-15       Impact factor: 4.739

7.  Combining anterior and posterior component separation for extreme cases of abdominal wall reconstruction.

Authors:  J Lopez-Monclus; J Muñoz-Rodríguez; C San Miguel; A Robin; L A Blazquez; M Pérez-Flecha; N Rupealta; M A Garcia-Urena
Journal:  Hernia       Date:  2020-03-05       Impact factor: 4.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.